2.9. Criteria for discontinuation of study drug and study drop-out
DISEASE PROGRESSION
Criteria for discontinuation of the study drug are: Completion of the planned 4 cycles; Disease progression according to RECIST v1.1, or unacceptable AEs requiring discontinuation of chemotherapy; Withdrawal of consent, and pregnancy.The drop-out criteria are; withdrawal of consent and; pregnancy.